Last checked at 14 Jan 2021 11:15
Ap19
FORM 8.3 - Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 11 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,785,376 | 2.16% | 680,874 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
354,221 | 0.27% | 604,791 | 0.47% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,139,597 | 2.44% | 1,285,665 | 1.00% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 12 | 203.1120 USD |
Purchase | 31 | 199.8000 USD |
Purchase | 45 | 202.9550 USD |
Purchase | 74 | 199.5500 USD |
Purchase | 100 | 199.5900 USD |
Purchase | 100 | 203.5575 USD |
Purchase | 100 | 203.1100 USD |
Purchase | 100 | 203.0300 USD |
Purchase | 100 | 202.8200 USD |
Purchase | 100 | 200.3700 USD |
Purchase | 100 | 199.7600 USD |
Purchase | 116 | 203.6224 USD |
Purchase | 120 | 200.5333 USD |
Purchase | 200 | 200.5050 USD |
Purchase | 200 | 199.5950 USD |
Purchase | 202 | 199.8326 USD |
Purchase | 209 | 203.5156 USD |
Purchase | 228 | 200.5430 USD |
Purchase | 328 | 200.3384 USD |
Purchase | 351 | 199.7570 USD |
Purchase | 390 | 199.9289 USD |
Purchase | 457 | 199.9140 USD |
Purchase | 485 | 203.4359 USD |
Purchase | 520 | 200.0726 USD |
Purchase | 625 | 200.0232 USD |
Purchase | 700 | 203.5389 USD |
Purchase | 1,000 | 199.7155 USD |
Purchase | 1,010 | 199.7740 USD |
Purchase | 1,218 | 200.1866 USD |
Purchase | 3,212 | 199.2300 USD |
Purchase | 4,134 | 200.0881 USD |
Purchase | 4,242 | 200.1138 USD |
Purchase | 6,567 | 200.1119 USD |
Purchase | 6,922 | 200.0934 USD |
Purchase | 7,137 | 201.7453 USD |
Purchase | 8,422 | 199.8021 USD |
Purchase | 12,974 | 201.2478 USD |
Purchase | 18,337 | 202.4577 USD |
Purchase | 32,305 | 201.3094 USD |
Purchase | 39,748 | 203.1446 USD |
Sale | 2 | 203.4300 USD |
Sale | 11 | 202.6472 USD |
Sale | 25 | 201.4100 USD |
Sale | 45 | 202.9550 USD |
Sale | 65 | 199.5500 USD |
Sale | 100 | 202.8500 USD |
Sale | 106 | 203.0177 USD |
Sale | 122 | 202.9150 USD |
Sale | 194 | 202.6825 USD |
Sale | 198 | 203.5638 USD |
Sale | 200 | 201.7950 USD |
Sale | 200 | 203.3125 USD |
Sale | 200 | 202.9800 USD |
Sale | 259 | 202.8301 USD |
Sale | 300 | 203.3650 USD |
Sale | 425 | 202.8407 USD |
Sale | 1,256 | 203.1103 USD |
Sale | 1,927 | 203.1284 USD |
Sale | 2,902 | 202.1232 USD |
Sale | 4,242 | 200.1138 USD |
Sale | 6,712 | 201.7083 USD |
Sale | 6,717 | 201.6243 USD |
Sale | 6,792 | 200.8114 USD |
Sale | 7,229 | 199.2300 USD |
Sale | 8,542 | 203.0101 USD |
Sale | 9,136 | 203.2162 USD |
Sale | 9,586 | 203.1582 USD |
Sale | 9,822 | 203.2203 USD |
Sale | 16,213 | 202.3648 USD |
Sale | 29,693 | 201.5101 USD |
Sale | 30,000 | 199.9878 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 14 Jan 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210114005490/en/
Copyright Business Wire 2021